Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Humanwell Puke Pharmaceutical is a specialized pharmaceutical company focused on the research, development, and large-scale manufacturing of softgel capsule formulations. As a subsidiary of Humanwell Healthcare Group, the company has established a significant presence in the international market, particularly in the United States, by adhering to stringent cGMP standards. Their product portfolio primarily includes over-the-counter (OTC) and prescription non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen. The company operates high-capacity manufacturing facilities in Wuhan that are FDA-inspected, positioning them as a key player in the global softgel supply chain. They also provide contract manufacturing and development services for complex oral solid dosage forms, leveraging their expertise in lipid-based drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 人福普克药业.